Pegfilgrastim, Indication, Dosage, Side Effect
Indication:
Pegfilgrastim is indicated to reduce the risk of infection in patients receiving chemotherapy that can cause neutropenia (a dangerously low level of white blood cells). It works by stimulating the bone marrow to produce more neutrophils, which are essential for fighting infections. Pegfilgrastim is especially useful in patients with cancers like breast, lung, or lymphoma who are undergoing strong chemotherapy that suppresses the immune system. It helps prevent complications like fever, infections, and treatment delays.
Dosage:
The typical dosage of Pegfilgrastim is 6 mg, given as a single subcutaneous (under the skin) injection once per chemotherapy cycle, at least 24 hours after chemotherapy ends. It’s used to help the body make more white blood cells and reduce the risk of infection in patients undergoing chemotherapy that lowers immune function. Pegfilgrastim is a long-acting form of filgrastim, designed to stay in the body longer and require fewer injections.
Extra notes:
It should not be given within 14 days before or 24 hours after chemotherapy, as this can increase side effects.
Most patients receive it once per cycle, often via an auto-injector device (Onpro) applied after chemo.
Common side effects include bone pain, which means the drug is working to boost white blood cells.
Side Effect:
The most common side effects of PEGFILGRASTIM are:
Aching or pain in the bones and muscles.
Take this medication regularly to get the most benefit from it. To help you remember, take it at the same times on the days your doctor directs.
This is not a complete list of possible side effects. Contact your doctor or pharmacist if you have any other side effects not listed above.
FAQ:
Frequently Asked Questions Regarding (Pegfilgrastim) / Generic NEULASTIM Pegfilgrastim:
May I inquire about the availability of the generic form of Pegfilgrastim, commonly referred to as/ NEULASTIM, for global distribution?
Certainly! We are able to distribute (Pegfilgrastim) globally, thanks to WTO regulations and our patient support program, which is specifically designed for individual patient treatments.
What’s the minimum order quantity for the generic version of Pegfilgrastim?
The smallest amount you can order of (Pegfilgrastim) depends on what the client or patient needs.
How much does the generic Pegfilgrastim, sold as or NEULASTIM in various countries, cost?
The price of (Pegfilgrastim) will be shared once we get a valid order from clients or patients.
How is it possible to procure (Pegfilgrastim), the generic version of NEULASTIM?
Kindly complete our order form for the purchase of (Pegfilgrastim).
How can I confirm I'm receiving authentic (Pegfilgrastim) or generic NEULASTIM?
We’re a licensed online pharmacy specializing in global generic prescription medication distribution. We directly work with manufacturers or authorized agents to ensure authentic (Pegfilgrastim) from us. Verify authenticity through the manufacturer’s security code. Contact us for any concerns or questions.
Will I get/ NEULASTIM Generic Pegfilgrastim without any complications?
Elifesaving Medicine, a globally recognized company, provides essential prescription medicines. We excel in online medicine delivery and assist patients in obtaining valid prescriptions and relevant documents. We offer consultation and facilitation for patients, hospitals, clinicians, and researchers, helping them access trustworthy sources, especially those unavailable or unapproved in their countries. Registered doctors and patients recommend us. Many clients provide feedback and referrals. We ensure smooth delivery of (Pegfilgrastim). Contact us immediately for any issues or doubts.
How can I pay for my preferred medicine?
To proceed with your order, please make an advance payment using your preferred method (Bank transfer, Credit card, Alipay, Western Union, MoneyGram, etc.). Once we confirm your payment, we'll process your order immediately.
Pegfilgrastim has different brand names depending on the manufacturer. Some of the brand names are: